ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 100 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 125 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 75 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 100 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 125 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 75 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - axitinib - טבליות מצופות פילם - axitinib 1 mg - axitinib - axitinib - for the treatment of advanced renal cell carcinoma (rcc) after failure of one prior systemic therapy.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - axitinib - טבליות מצופות פילם - axitinib 5 mg - axitinib - axitinib - for the treatment of advanced renal cell carcinoma (rcc) after failure of one prior systemic therapy.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - tofacitinib as citrate - טבליות עם שחרור נרחב - tofacitinib as citrate 11 mg - tofacitinib